Welcome to TERMIRA

TERMIRA AB is a Startup Company operating in the field of Regenerative Medicine. The company was founded in October 2007 in Stockholm Sweden and aims to provide high margin products to one of the fastest growing life science markets of today.

TERMIRA has an exclusive worldwide and irreversible license from IPR-Systems Sweden AB (IPRS) to use their IPR for the treatment of bone, cartilage and tendon defects. TERMIRA will market and supply hydrogel scaffolds in cooperation with IPRS for other applications. This includes delivering products to companies with separate licenses from IPRS.

In addition to the newly launched laboratory kit, AuxiGel™, TERMIRA is capable of producing various hyaluronic acid derivatives and gels, and bulk material may be provided on special request. TERMIRA is furthermore a supplier/sub-supplier of gel products to companies acting on Life Science markets, and is open to different forms of cooperation including Joint Ventures.

For more information or requests please contact Kristoffer Bergman, president of TERMIRA AB, on kristoffer@termira.com.